Tag: leading pharmaceutical companies

February 27, 2017

Pieris Signs 1st Partnership for Anemia Drug PRS-080, Granting Exclusive Option in Japan to ASKA Pharmaceutical

 Pieris Pharmaceuticals (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform, today announced that...
February 22, 2017

NeoGenomics Reports 122% Revenue Growth to $60.5 Million and 11% Reduction in Average Cost per Test in the Fourth Quarter of 2016

NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of cancer-focused genetic testing services, today reported its results for the fourth quarter...
December 9, 2016

Valneva Receives FDA and European Approvals to Start Clinical Testing of Lyme Disease Vaccine Candidate

Valneva today announced that its vaccine candidate VLA15 against Lyme disease is now progressing into clinical testing following the Investigational...
November 2, 2016

GE Healthcare and Valneva Collaboration Delivers Optimized Cell Culture Medium for Vaccine Production

GE Healthcare's Life Sciences business and Valneva, a fully integrated vaccine biotech company, are sharing the results of a successful...
October 24, 2016

Ligand Partner Melinta Therapeutics Submits Baxdela New Drug Application for Hospital-Treated Skin Infections

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) partner Melinta Therapeutics announced today that it has submitted New Drug Applications to the U.S....
October 7, 2016

Myriad Announces Four Poster Presentations at the 2016 ESMO Annual Meeting

Myriad Genetics, a leader in molecular diagnostics and personalized medicine, today announced that four poster presentations will be featured at...
September 19, 2016

AXIM® Biotech Signs Exclusive Distribution Agreement With Israel’s Rafa Pharmaceuticals

AXIM® Biotechnologies, Inc. (OTC:AXIM), an innovative biotechnology company focusing on research, development and production of pharmaceutical, nutraceutical and cosmetic products,...